切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2009, Vol. 03 ›› Issue (02) : 12 -14. doi: 10.3877/cma.j.issn.1674-0793.2009.02.004

论著

甲胎蛋白启动子驱动的yCDglyTK双自杀基因治疗裸鼠肝癌的机制研究
华赟鹏1,(), 赖佳明1, 李绍强1, 汪勇1, 王瑛2, 李宝金3, 朱宝益4   
  1. 1.510080 广州,中山大学附属第一医院肝胆外科
    2.510080 广州,中山大学附属第一医院超声科
    3.北京大学深圳医院肝胆外科
    4.中山大学医学院2004 级临床医疗系
  • 收稿日期:2008-12-09 出版日期:2009-04-01
  • 通信作者: 华赟鹏
  • 基金资助:
    广东省博士启动基金(05300772)

Study of yeast CDglyTK double suicide gene driven by AFP promoter for treatment of hepatocellular carcinoma in vivo

Yun-peng HUA1,(), Jia-ming LAI1, Shao-qiang LI1, Yong WANG1, Ying WANG1, Bao-jin LI1, Bao-yi ZHU1   

  1. 1.Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University,Guangzhou 510080,China
  • Received:2008-12-09 Published:2009-04-01
  • Corresponding author: Yun-peng HUA
引用本文:

华赟鹏, 赖佳明, 李绍强, 汪勇, 王瑛, 李宝金, 朱宝益. 甲胎蛋白启动子驱动的yCDglyTK双自杀基因治疗裸鼠肝癌的机制研究[J]. 中华普通外科学文献(电子版), 2009, 03(02): 12-14.

Yun-peng HUA, Jia-ming LAI, Shao-qiang LI, Yong WANG, Ying WANG, Bao-jin LI, Bao-yi ZHU. Study of yeast CDglyTK double suicide gene driven by AFP promoter for treatment of hepatocellular carcinoma in vivo[J]. Chinese Archives of General Surgery(Electronic Edition), 2009, 03(02): 12-14.

目的

研究携带甲胎蛋白(AFP)启动子的酵母菌胞嘧啶脱氨酶/胸苷激酶(yCDglyTK)双自杀基因体内靶向性治疗肝癌的效果和机制。

方法

构建携带AFP启动子的yCDglyTK双自杀基因表达质粒,通过阳离子脂质体将携带AFP启动子的yCDglyTK双自杀基因转染HepG2和SMMC7721肝癌细胞的裸鼠肝癌皮下种植瘤,观察自杀基因体内杀瘤效果以及细胞凋亡的情况。

结果

成功构建携带AFP启动子的yCDglyTK双自杀基因,其靶向性地在AFP阳性的HepG2细胞种植瘤上表达,而AFP阴性的SMMC7721细胞种植瘤上无表达,氟胞嘧啶(5-FC)、更昔洛韦(GCV)及两者联合可有效抑制HepG2细胞种植瘤的生长,抑瘤效果GCV+5-FC>5-FC>GCV,而SMMC7721细胞种植瘤的生长未受影响。HepG2细胞种植瘤治疗后有明显的细胞凋亡,而SMMC7721细胞种植瘤内极少凋亡细胞。

结论

携带AFP启动子的yCDglyTK双自杀基因能有效地靶向性地杀伤AFP阳性的肝癌细胞,细胞凋亡可能是其杀伤的重要机制之一。

Objective

To study the effects and mechanisms of yeast cytosine deaminase/thymidine kinase (yCDglyTK)double suicide gene driven by alpha fetoprotein (AFP)promoter on hepatocellular carcinoma(HCC) in vivo.

Methods

To construct the expression plasmid with yCDglyTK double suicide gene driven by AFP promoter,HepG2 (AFP positive)and SMMC7721 (AFP negative)human HCC cell xenografts in nude mice were both transfected with the above-mentioned expression plasmid through cationic liposome,followed by treatment of the prodrugs 5-fluorocytosine (5-FC) and/or ganciclovir (GCV). The effect of inhibition was observed through measuring the tumor size and the number of apoptosis cells.

Results

The double suicide gene was expressed selectively on HepG2 cell xenografts, rather than on SMMC7721 cells. The prodrugs 5-FC and/or GCV could inhibit effectively the growth of HepG2 cell xenografts,but had no influence on SMMC7721 cells. The inhibitive effects of different prodrugs on HepG2 cells were GCV+5-FC>5-FC>GCV.Apoptotic cells were found in HepG2 xenografts after the treatment of prodrugs. However, in SMMC7721 cell xenografts, few apoptotic cells were found.

Conclusions

yCDglyTK double suicide gene driven by AFP promoter has a significant efficacy in treatmentof AFP positive HCC.Cell apoptosis may be an important mechanism of inhibiting the growth ofHCC.

1
马曾辰.肝癌手术切除治疗的“利”与“弊”.中国普外基础与临床杂志,2007,14(1):1-4.
2
马毅,陈祖兵,华赟鹏.腺病毒阶段双自杀基因CD/TK 对人肝癌细胞株Bel7402 的抑制作用. 中华实验外科杂志, 2006, 23(5):537-539.
3
黄嘉凌,刘燕艳,方状伟,等.HSV-TK/CD 基因联合IL-12 基因体内治疗肝癌.肿瘤,2004,24(5):516-519.
4
Hallenbeck PL, Stevenson SC. Targetable gene delivery vector. Adv Exp Med Biol,2000,465(1):37-42.
5
Rogulski KR,Wing MS.Paielli DL,et al. Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization.Hum Gene Ther,2000,11(1):67-71.
6
Ishikawa H, Nakata K, Mawatari F, et al. Utilization of variant-type of human alpha-fetoprotein promoter in gene therapy targeting for hepatocellular carcinoma.Gene Ther,1999,6(4):465-469.
7
Stolworthy TS, Korkegian AM, Willmon CL, et al. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.J Mol Biol,2008,377(3):854-869.
[1] 李一鸣, 陈冠辉, 余东升. 石墨烯及其衍生物作为基因载体的研究进展[J]. 中华口腔医学研究杂志(电子版), 2018, 12(02): 131-134.
[2] 赵广峰, 朱易凡. 白细胞介素2基因转染对裸鼠乳腺癌肺转移的影响[J]. 中华普通外科学文献(电子版), 2017, 11(03): 164-167.
[3] 戴强生, 李鹤平, 龙健婷, 曾睿芳, 张冰, 周波, 幸思忠, 曾志荣, 陈伟, 杨建勇. β-葡萄糖神经酰胺与HBsAg-DC瘤苗协同治疗肝癌的实验研究[J]. 中华普通外科学文献(电子版), 2013, 07(04): 298-302.
[4] 赵坤, 叶小鸣. 2014年胆囊癌NCCN治疗指南解读与思考[J]. 中华肝脏外科手术学电子杂志, 2015, 04(02): 76-78.
[5] 孔祥琳, 黄尤光, 杨之斌, 程先硕, 李云峰. 重组可溶性Tie2对结肠癌生长及肝转移的抑制作用[J]. 中华结直肠疾病电子杂志, 2013, 02(03): 109-113.
[6] 汪东生, 吴理达, 顾雨春. 细胞基因疗法在视网膜退行性疾病中的应用和挑战[J]. 中华眼科医学杂志(电子版), 2022, 12(03): 129-133.
阅读次数
全文


摘要